Drug Shortage Report for AURO-GALANTAMINE ER

Last updated on 2024-12-17 History
Report ID 199650
Drug Identification Number 02425157
Brand name AURO-GALANTAMINE ER
Common or Proper name GALANTAMINE ER
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) GALANTAMINE
Strength(s) 8MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 30's and 100's
ATC code N06DA
ATC description ANTI-DEMENTIA DRUGS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2023-07-21
Estimated end date 2024-12-15
Actual end date 2024-12-16
Shortage status Resolved
Updated date 2024-12-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v52 2024-12-17 English Compare
v51 2024-12-16 French Compare
v50 2024-12-16 English Compare
v49 2024-11-15 French Compare
v48 2024-11-15 English Compare
v47 2024-10-25 French Compare
v46 2024-10-25 English Compare
v45 2024-09-27 French Compare
v44 2024-09-27 English Compare
v43 2024-09-27 French Compare
v42 2024-09-27 English Compare
v41 2024-09-13 French Compare
v40 2024-09-13 English Compare
v39 2024-08-13 French Compare
v38 2024-08-13 English Compare
v37 2024-07-29 French Compare
v36 2024-07-29 English Compare
v35 2024-07-08 French Compare
v34 2024-07-08 English Compare
v33 2024-07-02 French Compare

Showing 1 to 20 of 52